Multiple Sclerosis Treatment Options and Medication Monitoring

New Orleans, LA US
October 17, 2019

Worldwide, more than 2.3 million people have a diagnosis of Multiple Sclerosis. In the United States, there are nearly 1 million people over the age of 18 that are living with a diagnosis of MS. There are four different types of MS: clinically isolated syndrome, relapsing-remitting MS, secondary progressive MS, and primary progressive MS. Medical management of multiple sclerosis will help healthcare professionals understand what the best course of therapy for their patients is. Understanding how to monitor the medications for MS will help pharmacists and pharmacy technicians be able to track if a medication is effective for a patient. Healthcare professionals will know what to look out for in terms of each medication’s monitoring parameters in order to ensure a better safety profile for the patients. The presentation will cover the treatment options available for Multiple Sclerosis. The focus of this presentation will be to evaluate and discuss the evidence supporting the treatment of multiple sclerosis.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe the clinical presentation and diagnosis of patients with Multiple Sclerosis
  2. Discuss the pharmacotherapy options for Multiple Sclerosis including criteria for use, dosage forms, monitoring requirements, REMS components, and side effect management
  3. Describe mechanisms that can be used to manage side effects of MS medications

Pharmacy technician learning objectives

  1. Describe mechanisms that can be used to manage side effects of MS medications
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
10/17/2019 - 7:00pm CDT
Event ends: 
10/17/2019 - 8:00pm CDT
Ochsner Specialty Pharmacy
1405 Jefferson Highway
Suite A
New Orleans, LA 70121
United States
Relevant financial relationships: Planning committee members, reviewer and presenters have nothing to disclose
Planning committee members
Alicia Verret, PharmD, CSP
Supervisor – Pharmacy Lead
Ochsner Specialty Pharmacy
Sheena Babin, PharmD, CSP
Manager, Pharmacy Clinical Services and Business Development
Ochsner Specialty Pharmacy
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLA
Senior Clinical Manager
Alaa Elsayed, PharmD
Community Pharmacy Resident, PGY-1
Ochsner Specialty Pharmacy


Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Specialty Pharmacy.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-196-L01-P
Universal Activity Number: JA0006103-9999-19-196-L01-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance


Please login or register to take this course.